Navigation Links
Facet Life Sciences Appoints Tobias Massa, PhD to Board of Directors
Date:9/12/2017

Facet Life Sciences, a leading provider of development solutions (software and services) for small and growing life sciences teams, today announced that Tobias Massa, PhD has joined the company’s Board of Directors.

Dr. Massa brings 38 years of success in pharmaceuticals, biotech, life sciences, and technology to his Board position. Most recently he served as VP and Head of Global Regulatory Operations at Sanofi. During his tenure, he spearheaded multiple organizational change projects including the creation of an outsourcing program for non-strategic regulatory activity; strategic planning for the establishment of a regulatory outsourcing center; the consolidation of regulatory processes and tools; and the development of a foundation for the transition of traditional services to a multi-tenant cloud-based SaaS system. Prior to Sanofi, Dr. Massa spent ten years at Bristol-Myers Squibb where he led Global Regulatory CMC/Operations/ Mature Product Strategy.

Ken VanLuvanee, President and CEO, Facet Life Sciences, commented, “Toby has an incredible career-spanning track record of innovation. He understands life sciences R&D but more importantly, he has practical, experience-based insight into how we can improve it. His pioneering attitude aligns well with our innovative technology and service strategy designed for small teams. We look forward to his contributions as a member of the Facet Board of Directors.”

Dr. Massa added, “In the life sciences industry, so many novel products are being produced by very small development teams. This is the segment of the market where science and innovation are flourishing. I am excited to work with the Facet Life Sciences team because they are so dedicated to this under-served group.”

The Facet Life Sciences Board of Directors also includes Ken VanLuvanee, President and CEO and Lisa Jenkins VanLuvanee, Vice President, Research and Development.

About Facet Life Sciences
Facet Life Sciences is the leading provider of innovative development solutions (software and services) designed to help small teams get their INDs to and through the FDA. Our research and development specialists deliver expert services and cutting-edge technologies that speed product R&D efforts. Facet teams create and manage critical development documentation for some of the industry’s fastest growing life sciences companies.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14676958.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease
2. Elseviers Geofacets Adds More Than 80,000 Maps in Collaboration with The Geological Society of America
3. CNA Finance Initiates Research Coverage On NuLife Sciences
4. Beckman Coulter Life Sciences to Discuss Particles and Composition of Tuberculosis Vaccine
5. Akadeum Life Sciences, Inc. Recognized for Best New Technology at CYTO Innovation
6. Caprion Biosciences Expands Biomarker Panel Portfolio to Include Predictive Tuberculosis (TB) Infections
7. Panitch Schwarze Life Sciences Practice Leader Speaks at Biotechnology Conference in Shanghai
8. OHAUS Introduces New Line of Laboratory Equipment for the Life Sciences
9. ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug
10. Life Sciences Expert Navitas augments End-to-end Capabilities
11. Beckman Coulter Life Sciences to Showcase Analytical Methods to Measure Empty and Full AAV Particles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2018)... ... October 17, 2018 , ... PathSensors’ ... have been validated by USDA’s Animal and Plant Health Inspection Service for use ... assays with confidence and trust, knowing they will be able to rapidly and ...
(Date:10/16/2018)... ... October 16, 2018 , ... Infinity Healing Center, along with ... revolutionary technology that effectively treats pain, reduces the need for opioids, and lowers ... technology using photobiomodulation (PBM) has been effective for the treatment of medical conditions ...
(Date:10/16/2018)... ... ... The American Medical Informatics Association (AMIA) is proud to announce the 2018 Signature ... AMIA 2018 Annual Symposium , taking place Nov. 3 – 7, in San Francisco. ... 700 submissions. The AMIA Signature Awards program provides an opportunity for AMIA members at ...
(Date:10/11/2018)... ... October 10, 2018 , ... Boston Biotech Conferences, ... of Wendy Nelson, PhD, as its new CEO. , Dr. Nelson has over ... biotech industry. Most recently, Dr. Nelson was VP of Business Development, Marketing ...
Breaking Biology Technology:
(Date:10/18/2018)... , ... October 18, 2018 , ... On June 11 ... the emerging field of gene-editing therapeutics to hold its collective breath. Two different ... a high frequency of p53 gene mutation. Mutations in the p53 gene have ...
(Date:10/18/2018)... STATION, Texas (PRWEB) , ... October 18, 2018 ... ... step closer to reality , Texas A&M receives USDA-APHIS deregulation approval , Writer: ... into flour to deliver protein to millions of people, a project to which ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... life sciences, diagnostics, and scientific healthcare companies, proudly announces Insights: Scientific Healthcare ... South San Francisco. In conjunction with co-producer Biocom, the association representing the ...
Breaking Biology News(10 mins):